Treatment of Streptomycin-Susceptible and Streptomycin-Resistant Enterococcal Endocarditis
The DOI matches its Crossref record; 24 of the 25 references it cites were found in a registry or an index.
Abstract
Fifty-six patients with enterococcal endocarditis received 4 weeks of antimicrobial therapy with penicillin G and streptomycin (36 patients) or, if infections were streptomycin resistant, penicillin and gentamicin (20 patients). Compared with patients who had symptoms for less than 3 months, patients with symptoms for more than 3 months had a higher relapse rate (0% versus 44%; p less than 0.001) and mortality (2.5% versus 25%; p less than 0.001). Patients with mitral valve endocarditis had a significantly higher relapse rate (25%) than patients with aortic valve infections (0%) (p less than 0.01). Gentamicin-associated nephrotoxicity was more frequent (p less than 0.001) among patients treated with greater than 3 mg/kg d of gentamicin than among those treated with 3 mg or less (100% versus 20%). Relapse and mortality rates did not differ significantly between patients treated with low-dose or high-dose gentamicin regimens. Patients who have had symptoms of enterococcal endocarditis for more than 3 months or patients with mitral valve infection should receive at least 6 weeks of antimicrobial therapy, but patients without these high-risk factors can be treated for 4 weeks.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Patients with ≥3 months' duration of symptoms were successfully treated with 6 weeks of therapy.”
In the citing paper
“Patients with <3 months' duration of symptoms were treated successfully with 4 weeks of antimicrobial therapy.”
Citations
Cites
Infective Endocarditis in the Antibiotic Era
Lerner, P. I., & Weinstein, L. (1966) · New England Journal of Medicine · doi:10.1056/nejm196601272740407 · Cited by 595
Studies on antibiotic synergism against enterococci. I. Bacteriologic studies.
Rc, M., Wennersten, C. B., & Weinberg, A. N. (1971) · PubMed · Cited by 186
GERACI, J. E., & MARTIN, W. J. (1954) · Circulation · doi:10.1161/01.cir.10.2.173 · Cited by 155
Self-citationCombination Antibiotic Therapy of Bacterial Endocarditis
SANDE, M. A., & SCHELD, W. M. (1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-92-3-390 · Cited by 152
Self-citationMutanolysin, Bacteriolytic Agent for Cariogenic Streptococci: Partial Purification and Properties
Yokogawa, K., Kawata, S., Nishimura, S., Ikeda, Y., & Yoshimura, Y. (1974) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.6.2.156 · Cited by 144
Mandell, G. L. (1970) · Archives of Internal Medicine · doi:10.1001/archinte.1970.00310020064005 · Cited by 138
Antibiotic synergism of enterococci. Relation to inhibitory concentrations
Standiford, H. D. (1970) · Archives of Internal Medicine · doi:10.1001/archinte.126.2.255 · Cited by 135
Geraci, J. E. (1958) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)34262-6 · Cited by 123
Self-citationWilson, W. R. (1981) · JAMA · doi:10.1001/jama.245.4.360 · Cited by 121
Self-citationPenicillin and Gentamicin Therapy For Enterococcal Infections
Weinstein, A. J., & Moellering, R. C. (1973) · JAMA · doi:10.1001/jama.1973.03220090050011 · Cited by 114
Research works printed but not linked: 14
- KAYE D, 1961, Antimicrob Agents Chemother., 1, 37
- WILSON W, 1982, Mayo Clin Proc., 57, 81
- WILKOWSKE C, 1970, Antimicrob Agents Chemother., 10, 195
- FEKETY F, 1966, Antimicrob Agents Chemother., 6, 156
- 10.1001/jama.1981.03310290028017 · doi:10.1001/jama.1981.03310290028017 · Paper page
- TOMPSETT R, 1977, Trans Am Clin Climatol Assoc., 89, 49
- 10.1001/archinte.1970.00310080061006 · doi:10.1001/archinte.1970.00310080061006
- MOELLERING R, 1971, J Lab Clin Med., 77, 821
- 10.1001/archinte.1977.03630230050014 · doi:10.1001/archinte.1977.03630230050014
- FRIEDBERG C . Diseases of the Heart, vol. 1. 3rd ed. Philadelphia: W.B. Saunders Company; 1966:242.
- YU P, 1981, Laboratory Procedures in Clinical Microbiology., 133
- ANHALT J, 1981, Laboratory Procedures in Clinical Microbiology., 681
- MANDELL G, 1976, Infective Endocarditis., 101
- CARRIZOSA J, 1976, J Lab Clin Med., 88, 132
Cited by
Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Tleyjeh, I. M., Rybak, M. J., Barsic, B., Lockhart, P. B., Gewitz, M. H., Levison, M. E., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000296 · Cited by 3,232
“In a prospective study, the duration of antimicrobial therapy in native valve E faecalis IE was based on the duration of infection before diagnosis and onset of effective therapy.(196) Patients with <3 months’ duration of symptoms were treated successfully with 4 weeks of antimicrobial therapy.”
MethodSelf-citationWilson, W., Taubert, K. A., Gewitz, M., Lockhart, P. B., Baddour, L. M., Levison, M., Bolger, A., Cabell, C. H., Takahashi, M., Baltimore, R. S., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.183095 · Cited by 2,814
Self-citationThe life and times of the Enterococcus
Murray, B. E. (1990) · Clinical Microbiology Reviews · doi:10.1128/cmr.3.1.46 · Cited by 1,908
Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Bolger, A. F., Levison, M. E., Ferrieri, P., Gerber, M. A., Tani, L. Y., Gewitz, M. H., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.165564 · Cited by 1,707
Self-citationGould, F. K., Denning, D. W., Elliott, T. S. J., Foweraker, J., Perry, J. D., Prendergast, B. D., Sandoe, J. A. T., Spry, M. J., & Watkin, R. W. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr450 · Cited by 593
Metadata
- Authors
- WILSON, W. R., WILKOWSKE, C. J., WRIGHT, A. J., SANDE, M. A., & GERACI, J. E.
- Affiliations
- Rochester, Minnesota; and San Francisco, California
- Corresponding author
- WILSON, WALTER R.
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 1984-06-01
- Volume
- 100
- Issue
- 6
- Pages
- 816-823
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2037757788
- Semantic Scholar
- dacabe03390cdea6a357f94f3599da39f56d05f1
- Cited by
- 159
- References
- 25
- Citations by year
- 2025: 2 · 2024: 3 · 2023: 1 · 2022: 3 · 2021: 5 · 2020: 2 · 2019: 2 · 2018: 3 · 2017: 1 · 2016: 1 · 2015: 4 · 2014: 5 · 2013: 7 · 2012: 1
- FWCI
- 7.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.acpjournals.org/journal/aim/text-and-data-mining (tdm)
- Locations
- Annals of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Health Sciences › Medicine › Infectious Diseases › Streptococcal Infections and Treatments
- Health Sciences › Medicine › Ophthalmology › Ocular Infections and Treatments
- Keywords
- enterococcal endocarditis, streptomycin resistance, streptomycin, penicillin G, gentamicin, gentamicin nephrotoxicity, relapse, mortality, mitral valve endocarditis, aortic valve endocarditis, antibiotic duration, antibiotic dosing
- MeSH terms
- Adult, Aged, Drug Therapy, Combination, Endocarditis, Bacterial, Female, Gentamicins, Heart Failure, Heart Valve Diseases, Humans, Labyrinth Diseases, Male, Middle Aged, Mitral Valve, Penicillin G, Penicillin Resistance, Prospective Studies, Recurrence, Streptococcal Infections, Enterococcus faecalis, Streptomycin, Vestibule, Labyrinth
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Treatment of Streptomycin-Susceptible and Streptomycin-Resistant Enterococcal Endocarditis. https://app.cochat.ai/papers/10.7326/0003-4819-100-6-816
- The paper
- WILSON, W. R., WILKOWSKE, C. J., WRIGHT, A. J., SANDE, M. A., & GERACI, J. E. (1984). Treatment of Streptomycin-Susceptible and Streptomycin-Resistant Enterococcal Endocarditis. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-100-6-816
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.